Ridge BioRidge Bio
RB

Ridge Bio

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Website
2021Inactive
Advertise here

About

Ridge Bio is a biotechnology company focused on developing transformative gene therapies for patients with rare genetic diseases. Their platform aims to deliver precise and effective treatments by leveraging advanced gene editing and delivery technologies. The company is dedicated to addressing unmet medical needs and improving the lives of individuals affected by debilitating genetic conditions.

Technology stack

detected 2026-05-25
Est. monthly stack spend~$70/mo
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Ridge Bio do?

Ridge Bio is a biotechnology company focused on developing transformative gene therapies for patients with rare genetic diseases. Their platform aims to deliver precise and effective treatments by leveraging advanced gene editing and delivery technologies. The company is dedicated to addressing unmet medical needs and improving the lives of individuals affected by debilitating genetic conditions.

How much funding has Ridge Bio raised?

Ridge Bio has raised a total of $135M in funding. The most recent round on record is Seed.

Where is Ridge Bio headquartered?

Ridge Bio is headquartered in San Francisco, United States.

When was Ridge Bio founded?

Ridge Bio was founded in 2021.

What industry does Ridge Bio operate in?

Ridge Bio operates in Biotech, MedTech, HealthTech, Gene Therapy, Drug Discovery, Genomics.

What is Ridge Bio's current status?

Ridge Bio's current operating status is: Inactive.